Pubblicazioni

Autori:

Caminati, Marco; Brussino, Luisa; Carlucci, Matilde; Carlucci, Palma; Carpagnano, Lucia Federica; Caruso, Cristiano; Cosmi, Lorenzo; D'Amore, Simona; Del Giacco, Stefano; Detoraki, Aikaterini; Di Gioacchino, Mario; Matucci, Andrea; Mormile, Ilaria; Granata, Francescopaolo; Guarnieri, Gabriella; Krampera, Mauro; Maule, Matteo; Nettis, Eustachio; Nicola, Stefania; Noviello, Silvia; Pane, Fabrizio; Papayannidis, Cristina; Parronchi, Paola; Pelaia, Girolamo; Ridolo, Erminia; Rossi, Francesca Wanda; Senna, Gianenrico; Triggiani, Massimo; Vacca, Angelo; Vivarelli, Emanuele; Vultaggio, Alessandra; de Paulis, Amato

Titolo:

Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)

Anno:

2024

Tipologia prodotto:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Lingua:

Inglese

Referee:

No

Nome rivista:

CELLS

ISSN Rivista:

2073-4409

N° Volume:

13

Numero o Fascicolo:

14

Intervallo pagine:

1-14

Parole chiave:

eosinophils; hypereosinophilia; hypereosinophilic syndrome; management; mepolizumab; network; precision medicine

Breve descrizione dei contenuti:

Hypereosinophilic syndrome (HES) encompasses a heterogeneous and complex group of different subtypes within the wider group of hypereosinophilic disorders. Despite increasing research interest, several unmet needs in terms of disease identification, pathobiology, phenotyping, and personalized treatment remain to be addressed. Also, the prospective burden of non-malignant HES and, more in general, HE disorders is currently unknown. On a practical note, shortening the diagnostic delay and the time to an appropriate treatment approach probably represents the most urgent issue, even in light of the great impact of HES on the quality of life of affected patients. The present document represents the first action that the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC) has finalized within a wider project aiming to establish a collaborative national network on HES (InHES-Italian Network on HES) for patients and physicians. The first step of the project could not but focus on defining a common language as well as sharing with all of the medical community an update on the most recent advances in the field. In fact, the existing literature has been carefully reviewed in order to critically integrate the different views on the topic and derive practical recommendations on disease identification and treatment approaches.

Id prodotto:

144441

Handle IRIS:

11562/1155689

ultima modifica:

8 maggio 2025

Citazione bibliografica:

Caminati, Marco; Brussino, Luisa; Carlucci, Matilde; Carlucci, Palma; Carpagnano, Lucia Federica; Caruso, Cristiano; Cosmi, Lorenzo; D'Amore, Simona; Del Giacco, Stefano; Detoraki, Aikaterini; Di Gioacchino, Mario; Matucci, Andrea; Mormile, Ilaria; Granata, Francescopaolo; Guarnieri, Gabriella; Krampera, Mauro; Maule, Matteo; Nettis, Eustachio; Nicola, Stefania; Noviello, Silvia; Pane, Fabrizio; Papayannidis, Cristina; Parronchi, Paola; Pelaia, Girolamo; Ridolo, Erminia; Rossi, Francesca Wanda; Senna, Gianenrico; Triggiani, Massimo; Vacca, Angelo; Vivarelli, Emanuele; Vultaggio, Alessandra; de Paulis, Amato, Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC) «CELLS» , vol. 13 , n. 14 , 2024 , pp. 1-14

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo